Doptelet Sprinkle Granule
NDC Package 71369-010-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Doptelet Sprinkle (avatrombopag) granules is a medication used by people with chronic liver disease and a certain blood disorder (low platelet count) who are scheduled to have a medical or dental procedure. This formulation utilizes a granule delivery system. Marketed by Akarx, Inc., this product is identified by NDC 71369-010 and is authorized under FDA application NDA219696.

Identification & Billing

NDC Package Code
71369-010-30
Package Description
1 BOTTLE in 1 CARTON / 30 GRANULE in 1 BOTTLE
Product Code
71369-010
11-Digit Billing Format
71369001030
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 2045951 - avatrombopag 20 MG Oral Tablet
  • RxCUI: 2045951 - avatrombopag 20 MG (as avatrombopag maleate 23.6 MG) Oral Tablet
  • RxCUI: 2045952 - {10 (avatrombopag 20 MG Oral Tablet) } Pack
  • RxCUI: 2045952 - avatrombopag 40 MG Daily Dose, 20 MG Oral Tablet 10 Count Pack
  • RxCUI: 2045952 - avatrombopag 40 MG Daily Dose Carton Pack, 1 Blister Card, 10 Tablets Each

Clinical Specifications

Proprietary Name
Doptelet Sprinkle
Non-Proprietary Name
Avatrombopag
Substance Name
Avatrombopag Maleate
Dosage Form
Granule - A small particle or grain.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
AVATROMBOPAG MALEATE 10 mg/1
Usage Information
This medication is used by people with chronic liver disease and a certain blood disorder (low platelet count) who are scheduled to have a medical or dental procedure. Having a low platelet count increases the risk of too much bleeding during certain procedures. This medication increases the production of platelets by your body to help prevent too much bleeding from the procedure. Avatrombopag is also used to treat people with a certain blood disorder known as chronic immune thrombocytopenia-ITP. This is a condition where the amount of platelets in the blood is lower than normal. ITP can lead to serious bleeding problems. This medication increases the production of platelets by your body to help prevent too much bleeding from ITP.

Regulatory & Marketing

Labeler Name
Akarx, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA219696
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-25-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71369-010-30 identifies a specific commercial package of 1 bottle in 1 carton / 30 granule in 1 bottle of Doptelet Sprinkle, a human prescription drug labeled by Akarx, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This granule is formulated for oral use and contains avatrombopag maleate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Akarx, Inc. on July 25, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used by people with chronic liver disease and a certain blood disorder (low platelet count) who are scheduled to have a medical or dental procedure. Having a low platelet count increases the risk of too much bleeding during certain procedures. This medication increases the production of platelets by your body to help prevent too much bleeding from the procedure. Avatrombopag is also used to treat people with a certain blood disorder known as chronic immune thrombocytopenia-ITP. This is a condition where the amount of platelets in the blood is lower than normal. ITP can lead to serious bleeding problems. This medication increases the production of platelets by your body to help prevent too much bleeding from ITP.

How is this Akarx, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71369001030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71369-010-30
11-Digit CMS (5-4-2)
71369-0010-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.